Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Change in Acquisitions & Divestments (2016 - 2025)

Medifast (MED) has disclosed Change in Acquisitions & Divestments for 16 consecutive years, with $29.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments rose 474.99% year-over-year to $29.3 million, compared with a TTM value of $82.1 million through Dec 2025, up 198.21%, and an annual FY2025 reading of $82.1 million, up 198.21% over the prior year.
  • Change in Acquisitions & Divestments was $29.3 million for Q4 2025 at Medifast, up from $7.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $30.8 million in Q2 2025 and bottomed at $1.2 million in Q1 2022.
  • Average Change in Acquisitions & Divestments over 5 years is $9.6 million, with a median of $6.3 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments tumbled 66.53% in 2022, then surged 474.99% in 2025.
  • Year by year, Change in Acquisitions & Divestments stood at $1.4 million in 2021, then soared by 182.25% to $4.0 million in 2022, then rose by 29.09% to $5.2 million in 2023, then fell by 1.81% to $5.1 million in 2024, then soared by 474.99% to $29.3 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for MED at $29.3 million in Q4 2025, $7.5 million in Q3 2025, and $30.8 million in Q2 2025.